Literature DB >> 15254438

Women and human immunodeficiency virus: unique management issues.

Rebecca A Clark1, Jeanne Dumestre.   

Abstract

Women currently account for an increasing proportion of the US population infected with human immunodeficiency virus (HIV). Although women suffer from similar HIV-related complications as men, they also can have unique gynecologic manifestations, such as cervical dysplasia or severe pelvic inflammatory disease. Other gender-specific management issues include contraception and pregnancy. Fortunately, today the perinatal HIV transmission rate can be lowered to less than 2% with appropriate management. More couples, including those discordant for HIV infection, are opting to pursue conception. Providers caring for HIV-infected women should be knowledgeable about reproductive choices, including the full array of available options. Strategies shown to improve access of health care to HIV-infected women include integrating gynecologic services with primary care, daily availability of medical services, provision of transportation, and provision of on-site childcare.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254438     DOI: 10.1097/00000441-200407000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Impact of HIV-1 infection and pregnancy on maternal health: comparison between perinatally and behaviorally infected young women.

Authors:  Iona Munjal; Joanna Dobroszycki; Esra Fakioglu; Michael G Rosenberg; Andrew A Wiznia; Mindy Katz; Aileen Steiner; Jorge Sansary; Moonseong Heo; Jacobo Abadi
Journal:  Adolesc Health Med Ther       Date:  2013-02-21

Review 2.  Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS.

Authors:  Allison J Carter; Sonya Bourgeois; Nadia O'Brien; Kira Abelsohn; Wangari Tharao; Saara Greene; Shari Margolese; Angela Kaida; Margarite Sanchez; Alexis K Palmer; Angela Cescon; Alexandra de Pokomandy; Mona R Loutfy
Journal:  J Int AIDS Soc       Date:  2013-01-11       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.